TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

A recent study published in Journal for Immunotherapy of Cancer investigates the utility of DNA barcoded peptide-major histocompatibility complex (pMHC) multimers in detecting and monitoring minor...

Study findings support the oral microbiome as a potential pathway for preventing or managing chronic graft-versus-host disease (cGVHD) following hematopoietic cell transplantation (HCT).

Recent studies from Vall d’Hebron University Hospital, Heidelberg University Hospital, and the European Society for Blood and Marrow Transplantation (EBMT) provide valuable insights into the...

While both are accepted rescue therapies for classic Hodgkin lymphoma (cHL) relapse, research suggests immune checkpoint inhibitors (ICIs) offer an advantage over chemotherapy.

Researchers from Bambino Gesù Children’s Hospital and Sapienza University in Rome, Italy examined the recovery and function of mucosal-associated invariant T (MAIT) cells in pediatric and...

Clinical trial evidence supports the use of itacitinib plus routine prophylaxis to prevent graft-versus-host disease (GVHD) and cytokine release syndrome (CRS) following haploidentical...